关注
Daniel Wong
Daniel Wong
在 nus.edu.sg 的电子邮件经过验证
标题
引用次数
引用次数
年份
Discovery and investigation of anticancer ruthenium–arene Schiff-base complexes via water-promoted combinatorial three-component assembly
MJ Chow, C Licona, D Yuan Qiang Wong, G Pastorin, C Gaiddon, ...
Journal of Medicinal Chemistry 57 (14), 6043-6059, 2014
1402014
Induction of immunogenic cell death by chemotherapeutic platinum complexes
DYQ Wong, DYQ Wong
Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno …, 2018
1352018
Immuno‐chemotherapeutic platinum (IV) prodrugs of cisplatin as multimodal anticancer agents
DYQ Wong, CHF Yeo, WH Ang
Angewandte Chemie International Edition 53 (26), 6752-6756, 2014
1122014
Anticancer platinum (IV) prodrugs with novel modes of activity
C Fei Chin, D Yuan Qiang Wong, R Jothibasu, W Han Ang
Current topics in medicinal chemistry 11 (21), 2602-2612, 2011
842011
Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience
D Mollengarden, K Goldberg, D Wong, C Roehrborn
Prostate cancer and prostatic diseases 21 (3), 379-385, 2018
662018
Structural determinants of p53-independence in anticancer ruthenium-arene schiff-base complexes
MJ Chow, MV Babak, DYQ Wong, G Pastorin, C Gaiddon, WH Ang
Molecular Pharmaceutics 13 (7), 2543-2554, 2016
522016
Urology residency applications in the COVID-19 era
AP Kenigsberg, RK Khouri Jr, A Kuprasertkul, D Wong, V Ganesan, ...
Urology 143, 55-61, 2020
482020
Harnessing chemoselective imine ligation for tethering bioactive molecules to platinum (IV) prodrugs
DYQ Wong, JY Lau, WH Ang
Dalton Transactions 41 (20), 6104-6111, 2012
442012
Induction of targeted necrosis with HER2-targeted platinum (IV) anticancer prodrugs
DYQ Wong, DYQ Wong
Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno …, 2018
352018
Real-world application of pre-orchiectomy miR-371a-3p test in testicular germ cell tumor management
RR Badia, D Abe, D Wong, N Singla, A Savelyeva, N Chertack, SL Woldu, ...
The Journal of urology 205 (1), 137-144, 2021
332021
Reversing the decline in urology residency applications: an analysis of medical school factors critical to maintaining student interest
D Wong, V Ganesan, I Kuprasertkul, RK Khouri Jr, GE Lemack
Urology 136, 51-57, 2020
262020
Serum small RNA sequencing and miR-375 assay do not identify the presence of pure teratoma at postchemotherapy retroperitoneal lymph node dissection
JT Lafin, AP Kenigsberg, X Meng, D Abe, A Savelyeva, N Singla, ...
European urology open science 26, 83-87, 2021
242021
Assessing the female and underrepresented minority medical student experience in the urology match: where do we fall short?
D Wong, A Kuprasertkul, RK Khouri Jr, V Ganesan, AP Kenigsberg, ...
Urology 147, 57-63, 2021
202021
The reactions of dimethyl 2, 5-bis (diazo)-3, 4-dikentoadipate with aromatic and heteroaromatic compounds
CW Bird, CK Wong, DY Wong, FLK Koh
Tetrahedron 32 (2), 269-274, 1976
141976
Organophosphorus intermediates—II: Deoxygenative dimerisation of maleic anhydrides by triethyl phosphite
CW Bird, DY Wong
Tetrahedron 31 (1), 31-32, 1975
141975
Phenotypic severity scoring system and categorisation for prune belly syndrome: application to a pilot cohort of 50 living patients
DG Wong, MK Arevalo, NM Passoni, NS Iqbal, T Jascur, AJ Kern, ...
BJU international 123 (1), 130-139, 2019
122019
Does grossly complete transurethral resection improve response to neoadjuvant chemotherapy?
RA Ghandour, S Kusin, D Wong, X Meng, N Singla, Y Freifeld, A Bagrodia, ...
Urologic Oncology: Seminars and Original Investigations 38 (9), 736. e11-736 …, 2020
92020
Platinum (IV) carboxylate prodrug complexes as versatile platforms for targeted chemotherapy
JX Ong, SQ Yap, DYQ Wong, CF Chin, WH Ang
Chimia 69 (3), 100-100, 2015
92015
The dehydrochlorination of succinyl chlorides
CW Bird, DY Wong
Tetrahedron 30 (15), 2331-2335, 1974
71974
Retzius sparing prostatectomy effect on symptomatic lymphocele rates
D Wong, J Rincon, G Henning, Z Smith, E Kim
Urology 149, 129-132, 2021
62021
系统目前无法执行此操作,请稍后再试。
文章 1–20